Nomura Asset Management International »

Halozyme Therapeutics shares owned by Nomura Asset Management International

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Nomura Asset Management International from 13F filings

Historical chart of Nomura Asset Management International investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Nomura Asset Management International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Nomura Asset Management International

Quarter filed Position value Share count Share price at filing
2026-03-31 $77M 1.2M 64.63